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Abstract
Survival analysis is one of the most important fields of statistics in medicine and the biological sciences. In addition, the
computational advances in the last decades have favoured the use of Bayesian methods in this context, providing a flexible
and powerful alternative to the traditional frequentist approach. The objective of this paper is to summarise some of the
most popular Bayesian survival models, such as accelerated failure time, proportional hazards, mixture cure, competing risks,
frailty, and joint models of longitudinal and survival data. Moreover, an implementation of each presented model is provided
using a BUGS syntax that can be run with JAGS from the R programming language. Reference to other Bayesian R-packages
are also discussed.
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1 Introduction
Survival analysis, sometimes referred to as failure-time analysis, is one of the most important fields of statistics, mainly
in medicine and the biological sciences (Kleinbaum and Klein, 2012; Collett, 2015). Survival times are data that measure
follow-up time from a defined starting point to the occurrence of a given event of interest or endpoint, for instance, onset
of disease, cure, death, etc. (Kalbfleisch and Prentice, 2002). Standard statistical techniques cannot usually be applied to
survival data because the underlying distribution is rarely Normal. This is due to the presence of incomplete information, such
as variable response (time-to-event) being strictly positive, censoring time and/or truncation (Klein et al., 2013). From these
peculiar characteristics and extreme relevance in different scientific subjects, survival models/methods have been developed
extensively over the past 50 years, which includes many R-packages†. In order to illustrate for which situations some survival
models are more appropriate than others, we summarise the main models for survival data, such as accelerated failure time,
proportional hazards, mixture cure, competing risks, frailty, and joint models of longitudinal and survival data. In particular,
the inferential process is performed from a Bayesian perspective, which is an appealing alternative to the traditional frequentist
approach (Ibrahim et al., 2001). Based on the Bayesian paradigm, we exemplify each survival modelling using Markov chain
Monte Carlo (MCMC) methods (Gelman et al., 2013) implemented in BUGS syntax (Gilks et al., 1994) with the support of
JAGS (Plummer, 2003) and the rjags (Plummer, 2018) package for the R language (R Core Team, 2018).
The paper is organised as follows: in Section 2 we introduce a brief summary of Bayesian survival models that will be
analysed. In Section 3, we present survival datasets available in R-packages, details of the BUGS code implementation from
the R language, posterior summaries, and graphs of quantities derived from the posterior distribution for each survival model.
Finally, Section 4 ends with a discussion about the importance and usefulness of reviewing survival models and providing
their codes in an easily adapted syntax.
2 Bayesian survival models
The two key elements that characterise the Bayesian reasoning in statistics with regard to the frequentist one are the conception
of probability, that allows to measure the uncertainty associated to parameters, models, hypotheses, missing data, etc. in
probabilistic terms, and the use of Bayes’ theorem to sequentially update probabilities as more relevant information is obtained.
As a result, Bayes inference offers a wide and attractive framework to survival analysis: the knowledge on relevant outcomes
in survival studies such as survival probabilities, median event times, or predictive event times can be directly assessed in
probabilistic terms.
Let T be a non-negative continuous random variable which represents time between an initiating event and an event (or
endpoint) of interest. Its probabilistic behaviour can be equivalently described by the survival function and the hazard function:
∗E-mail: dalvares@mat.uc.cl
†https://cran.r-project.org/web/views/Survival.html
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• Survival function, S(t) = P (T > t), t > 0. This is an unconditional probability, a non-increasing function with
S(0) = 1 and S(t)→ 0 as t→∞, and it is the related to its cumulative distribution function as F (t) = 1− S(t).
• Hazard function at time t, h(t). It is the instantaneous rate of event occurrence among the population that is still at risk
at time t:
h(t) = lim
∆t→0
P (t ≤ T < t+ ∆t | T ≥ t)
∆t
=
f(t)
S(t)
, t > 0,
where f(t) is the density function of T . Note that h(t) ≥ 0 and ∫ h(t) dt =∞. The hazard function is defined in terms
of a conditional probability but is not a probability. It could be interpreted as the approximate instantaneous probability
of having the event given that the target individual is alive at time t. The hazard rate is the model counterpart of the
incidence rate in epidemiological studies.
Censoring is the main responsible that traditional statistical methods do not apply for survival analysis. The observation of
survival times requires to spend some waiting time until the event of interest occurs. In most survival analyses, the study ends
without the observation of the event of interest in all the individuals in the study: the event has occurred for some subjects
but not for others which survival times are censored. The statistical inference of censored data depends on the particular
characteristics of the censoring mechanism. There are different type of censoring, such as right censoring, left censoring, and
interval censoring as well as several types of censoring schemes within both left and right censoring (Klein and Moeschberger,
2003). The censoring mechanism can be independent or not of the event time as well as informative or not. This is the case
when the censoring distribution does not depend on any of the same event time parameters. We will consider administrative
censoring in all materials in this paper: the end of the study is not random and, consequently, non-informative.
The main elements of a Bayesian learning process are the prior distribution, the likelihood function and the prior dis-
tribution, which is obtained from the first two elements via Bayes’ theorem. Censoring is only relevant for constructing the
likelihood function and plays no role in eliciting a prior distribution or in interpreting the results from the posterior distribution
(Ibrahim et al., 2001).
2.1 Survival regression models
Regression models focus on the association between the time-to-event random variable and baseline covariates (explanato-
ry/predictor variables or risk factors). These models allow the comparison of survival times between groups both with regard
to the general behaviour of the individuals in each group as well as prediction for new members of them. There are different
approaches to survival regression models. The most popular are the accelerated failure time (AFT) models and the proportional
hazards (PH) models, also known as the Cox models (Cox, 1972) in honor to this eminent scientist.
2.1.1 Accelerated failure time models
AFT models are the survival counterpart of linear models. The event time for each individual of the target population is
expressed, in logarithmic scale, in terms of a linear combination of covariates x with regression coefficients β plus a measure-
ment error:
log(T ) = x>β + ξ, (1)
where ξ is a random measurement error usually expressed in terms of a log-normal, a logistic or an extreme value (Gumbel)
probabilistic distribution. The particular case of a extreme value random error modelled by means of ξ = σ implies a
conditional (on β and σ) Weibull survival model for T with shape α = 1/σ and scale λ(β, σ) = exp
{−x>β/σ} parameters
(Christensen et al., 2011).
2.1.2 Proportional hazards models
The Cox proportional hazards model (Cox, 1972) is the most popular regression model in survival analysis. It expresses the
hazard function h(t) of the survival time of each individual of the target population as the product of a common baseline
hazard function h0(t), which determines the shape of h(t), and an exponential term which includes the relevant covariates x
with regression coefficients β as follow:
h(t | h0,β) = h0(t) exp
{
x>β
}
. (2)
The estimation of the regression coefficients in the Cox model under the frequentist approach can be obtained without
specifying a model for the baseline hazard function by using partial likelihood methodology (Cox, 1972). This is not the
case of Bayesian analysis which in general needs to specify some model for the baseline hazard (Christensen et al., 2011).
Depending on the context of the study, baseline hazard misspecification can imply a loss of valuable model information that
makes it impossible to fully report the estimation of the outcomes of interest, such as probabilities or survival curves for
relevant covariate patterns (Royston, 2011). This is specially important in survival studies where h0(t) represents the natural
course of a disease or an infection, or even the control group when comparing several treatments.
In the Bayesian framework, baseline hazard functions can be defined through parametric or non-parametric approaches.
Parametric models give restricted shapes which do not allow the presence of irregular behaviour (Dellaportas and Smith, 1993;
Kim and Ibrahim, 2000). Non-parametric choices result in more flexible baseline hazard shapes that allow for multimodal
patterns such as piecewise constant functions (Sahu et al., 1997) or spline functions (Hastie et al., 2009). However, they may
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suffer from overfitting and instability (Breiman, 1996). Regularisation methods try to modify the estimation procedures to
give reasonable answers to these types of situations. Bayesian reasoning usually accounts for regularisation through prior
distributions (La´zaro et al., 2020).
2.2 Cure models
Cure models deal with target populations in which a part of the individuals cannot experience the event of interest. This type
of model has widely been matured as a consequence of the discovery and development of new treatments against cancer. The
rationale of considering a cure subpopulation comes from the idea that a successful treatment removes totally the original
tumor and the individual cannot experience any recurrence of the disease. These models allow to estimate the probability of
cure, a key and valuable outcome in cancer research.
Mixture cure models are the most popular cure models (Berkson and Gage, 1952). They consider that the target population
is a mixture of susceptible and non-susceptible individuals. Let Z be a cure random variable defined as Z = 0 for susceptible
individuals of experiencing the event of interest and Z = 1 for cured or immune individuals for that event. Cure and non cure
probabilities are P (Z = 1) = η and P (Z = 0) = 1 − η, respectively. The survival function for each individual in the cured
and uncured subpopulation, Sc(t) and Su(t), t > 0, respectively, is
Su(t) = P (T > t | Z = 0),
Sc(t) = P (T > t | Z = 1).
(3)
The general survival function for T can be expressed in terms of a mixture of both cured and uncured subpopulations in
the form
S(t) = P (T > t) = η + (1− η)Su(t).
It is important to point out that Su(t) is a proper survival function but S(t) is not. It goes to η and not to zero when t goes
to∞. Cure fraction η is also known as the incidence model and time-to-event T in the uncured subpopulation as the latency
model (Klein et al., 2013).
The effect of a baseline covariate vector x on the cure fraction for each individual is typically modelled by means of
a logistic link function, logit(η) but the probit link or the complementary log-log link could also be used. Covariates for
modelling T in the uncured subpopulation are usually considered via Cox models.
2.3 Competing risks models
Competing risks occur when the survival process includes more than one cause of failure. In the case of different causes of
death it is only possible to report the first event to occur (Putter et al., 2007). There are different approaches for competing risk
models: multivariate time to failure model, the cause-specific hazards model, the mixture model, the subdistribution model,
and the full specified subdistribution model (Ge and Chen, 2012). We will only consider here the cause-specific hazards
model, possibly the most popular of them.
Let Tk be the random variable that represents individual time-to-event from cause k, k = 1, . . . ,K. The only survival
time observed T = min{T1, T2, . . . , TK} usually corresponds to the earliest cause together with their cause indicator δ, with
δ = k when the subsequent individual has experienced the event due to cause k.
The key concept in a competing risk model is the cause-specific hazard function for cause k, which assesses the hazard of
experiencing the event k in the presence of the rest of competing events:
hk(t) = lim
∆t→0
P (t ≤ T < t+ ∆t, δ = k | T ≥ t)
∆t
. (4)
Inference for each hk(t) considers the observed failure times for cause k as censored observations for the rest of events.
Another relevant concept in competing models is the cumulative incidence function for cause k, defined as the probability
Fk(t) = P (T ≤ t, δ = k). It can be expressed in terms of the cause-specific hazard function as follow:
Fk(t) =
∫ t
0
hk(u)S(u) du, (5)
where S(t) is the overall survival function and its expression in terms of the different cause-specific hazard functions is
S(t) = P (T > t) = exp
{
−
K∑
k=1
∫ t
0
hk(u) du
}
.
The cumulative incidence function is not a proper cumulative distribution function: Fk(∞) = P (δ = k) 6= 1, the
probability that the subsequent individual fails from cause k. The sub-survival function for cause k is defined as:
Sk(t) = P (T > t, δ = k) = 1− Fk(t),
and it is not a proper survival function.
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2.4 Frailty models
Regression models include measurable covariates to improve the knowledge of the relevant failure times. However, in most
survival studies, there are other relevant factors closely related to the survival variable that are not observable. These elements
are known in the statistical framework as random effects, but in the context of survival models they are the frailty elements.
They can approach individual characteristics as well as heterogeneity in groups or clusters (Ibrahim et al., 2001).
The most popular type of frailty models is the multiplicative shared-frailty model, which is a generalisation of the Cox
regression model introduced by Clayton (1978) and extensively studied in Hougaard (2000). Let Ti the survival time for each
individual in group i, i = 1, . . . , G with hazard function described by:
h(t | h0,β, wi) = wi h0(t) exp
{
x>β
}
, (6)
where wi is the frailty term associated to group i. The usual probabilistic model for the frailty terms is a Gamma distribution
with mean equal to one for identifiability purposes (Vaupel et al., 1979). In addition, a unity mean can be considered as a
neutral frontier because frailty values greater (lower) than one increases (decreases) the individual risk. An alternative way of
incorporating the frailty term is via an additive element as follows:
h(t | h0,β, bi) = h0(t) exp
{
x>β + bi
}
,
where now the bi’s are normally distributed with zero mean and unknown variance.
Frequentist frailty models based on the specification of the hazard function have some drawbacks because the frequentist
hazard function is not random but is is expressed in terms of random variables, the frailties. This situation does not occur in
the Bayesian framework which assigns probability to all unknown terms of a statistic model (rates, parameters, hypotheses,
etc.). Survival modelling with frailty terms is a wide issue of research that applies to all type of regression, competing risks,
multivariate survival models, etc. and play a special role in joint models as we will discuss below.
2.5 Joint models of longitudinal and survival data
Joint modelling of longitudinal and time-to-event data is an increasingly productive area of statistical research that examines
the association between longitudinal and survival processes (Rizopoulos, 2012). It enhances survival modelling with the in-
clusion of internal time-dependent covariates as well as longitudinal modelling by allowing for the inclusion of non-ignorable
dropout mechanisms through survival tools. Joint models were introduced during the 90s (DeGruttola and Tu, 1994; Tsiatis
et al., 1995; Faucett and Thomas, 1996; Wulfsohn and Tsiatis, 1997) and since then, have been applied to a great variety of
studies in epidemiological and biomedical areas.
Bayesian joint models assume a full joint distribution for the longitudinal (y) and the survival processes (s) as well as the
subject-specific random effects vector (b) and the parameters and hyperparameters (θ) of the model (Armero et al., 2018).
They can be defined generally as:
f(y, s, b,θ) = f(y, s | b,θ)f(b | θ)pi(θ), (7)
which factorises as the product of the joint conditional distribution f(y, s | b,θ), the conditional distribution f(b | θ) of the
random effects, and the prior distribution pi(θ).
There are different proposals for the specification of the conditional distribution f(y, s | b,θ). The most popular ap-
proaches are the share-parameter models, the random-effects models, and the joint latent class models.
Shared-parameter models are a type of joint models where the longitudinal and time-to-event processes are connected
by means of a common set of subject-specific random effects. These models make possible to quantify both the population
and individual effects of the underlying longitudinal outcome on the risk of an event and obtain individualised time-dynamic
predictions (Wu and Carroll, 1988; Hogan and Laird, 1997, 1998). In particular, this approach postulates conditional indepen-
dence between the longitudinal and survival processes given the random effects and the parameters:
f(y, s | b,θ) = f(y | b,θ)f(s | b,θ).
A clear disadvantage of these models is the stiffness of the correlation structure between the longitudinal and the survival
processes. The random-effects approach (Henderson et al., 2000) has the same structure that the shared-parameter models but
allows for more flexibility (and thus more complexity) for the connection between the survival and the longitudinal processes,
enabling that a part of the random effects associated to both processes are not common:
f(y, s | b,θ) = f(y | by,θ)f(s | bs,θ).
The joint latent class model (Proust-Lima et al., 2014) is based on finite mixtures: the heterogeneity among the individuals
is classified into a finite number G of homogeneous latent clusters which share the same longitudinal trajectory and the same
risk function which are also conditionally independent within the subsequent latent group:
f(y, s | L = g, b,θ) = f(y | L = g, b,θ)f(s | L = g,θ),
where L is the random variable that measures the uncertainty on the membership of each individual to each group usually
modelled by means of a multinomial logistic model. These models are possibly the most complex. They are not specially
suited for the estimation of the longitudinal trajectories but they are particularly well designed for prediction purposes.
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All these proposals account for a particular type of conditional independence between the longitudinal and the survival
processes which facilitates the modelling into longitudinal and survival submodels with various types of connectors. This
general structure allows any kind of modelling for the survival process such as frailty survival regression models, competing
risks with frailties, cure models with frailties as well as linear mixed models or generalised linear mixed models for the
longitudinal process (Taylor et al., 2013; Rizopoulos et al., 2015; Armero et al., 2016; Rue´ et al., 2017).
3 Illustrations
3.1 Accelerated failure time models
The illustration of an accelerated failure time model is based on a larynx cancer dataset, referred to as larynx, that is available
from the KMsurv R-package (Klein et al., 2012):
R> library(KMsurv)
R> data(larynx)
R> head(larynx)
stage time age diagyr delta
1 1 0.6 77 76 1
2 1 1.3 53 71 1
3 1 2.4 45 71 1
4 1 2.5 57 78 0
5 1 3.2 58 74 1
6 1 3.2 51 77 0
This dataset provides observations of 90 male larynx-cancer patients, diagnosed and treated in the period 1970–1978
(Kardaun, 1983). The following variables were observed for each patient:
• stage: disease stage (1–4).
• time: time (in months) from first treatment until death, or end of study.
• age: age (in years) at diagnosis of larynx cancer.
• diagyr: year of diagnosis of larynx cancer.
• delta: death indicator (1: if patient died; 0: otherwise).
3.1.1 Model specification
Survival times are analysed through an accelerated failure time (AFT) model (see Section 2.1):
log(T ) = β1 + β21(stage=2) + β31(stage=3) + β41(stage=4) + β5age + β6diagyr + σ, (8)
where T represents death time for each individual; β1 is an intercept; 1(stage=·) is an indicator variable for stage=2,3,4
with regression coefficients β2, β3, and β4, respectively (stage=1 is considered as the reference category); and β5 and β6 are
regression coefficients for age and diagyr covariates, respectively. The errors ’s are i.i.d. random variables which follow
a standard Gumbel distribution, as discussed in Section 2.1.
The Bayesian model is completed with the specification of a prior distribution for their corresponding parameters. A non-
informative prior independent default scenario is considered. The marginal prior distribution for each regression coefficient
βk, k = 1, . . . , 6, is elicited as a normal distribution centered at zero and a small precision, denoted as N(0,0.001). A uniform
distribution, Un(0,100), is selected as the marginal prior distribution for σ.
3.1.2 Model definition
Censoring is handled in JAGS using the distribution dintervalwhich implies the modification of the default time variable
and the creation of two new ones, cens and is.censored, according to the following terms:
• time: survival time is time if the event was observed (delta=1); otherwise, NA.
• cens: censoring time is time if the event was unobserved (delta=0); otherwise, 0.
• is.censored: censoring indicator taking the value 1 if the event was unobserved; otherwise, 0.
So, the following code is dedicated to creating or transforming these variables:
R> # Survival and censoring times
R> cens <- larynx$time
R> larynx$time[larynx$delta == 0] <- NA # Censored
R> cens[larynx$delta == 1] <- 0 # Uncensored
R> is.censored <- as.numeric(is.na(larynx$time))
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Next, we have scaled the age and diagyr, and encoded the stage as a factor. Then, we have created a design matrix
X of these covariates:
R> larynx$age <- as.numeric(scale(larynx$age))
R> larynx$diagyr <- as.numeric(scale(larynx$diagyr))
R> larynx$stage <- as.factor(larynx$stage)
R> X <- model.matrix(˜ stage + age + diagyr, data=larynx)
Listing 1 shows a generic implementation of an AFT model in BUGS syntax using the larynx data.
Listing 1: AFT model in BUGS syntax (file named as AFT.txt).
1 model{
2 f o r ( i i n 1 : n ){
3 # S u r v i v a l and c e n s o r i n g t i m e s
4 i s . c e n s o r e d [ i ] ˜ d i n t e r v a l ( t ime [ i ] , c ens [ i ] )
5 t ime [ i ] ˜ dweib ( a lpha , lambda [ i ] )
6 lambda [ i ] <- exp ( -mu[ i ]∗ a l p h a )
7 mu[ i ] <- i n p r o d ( b e t a [ ] ,X[ i , ] )
8 }
9
10 # P r i o r d i s t r i b u t i o n s
11 f o r ( l i n 1 : Nbe tas ){ b e t a [ l ] ˜ dnorm ( 0 , 0 . 0 0 1 ) }
12 s igma ˜ d u n i f ( 0 , 1 0 0 )
13 a l p h a <- 1 / s igma
14 }
3.1.3 Model estimation: JAGS from R
Once the BUGS syntax and its corresponding variables has been created, JAGS requires specifying some elements to run the
MCMC simulation:
• d.jags: a list with all the elements/data specified in the model.
• i.jags: a function that returns a list of initial random values for each model parameters.
• p.jags: a character vector with the parameter names to be monitored/saved.
These elements are defined for our AFT model as follows:
R> d.jags <- list(n=nrow(larynx), time=larynx$time, cens=cens, X=X,
+ is.censored=is.censored, Nbetas=ncol(X))
R> i.jags <- function(){ list(beta=rnorm(ncol(X)), sigma=runif(1)) }
R> p.jags <- c("beta", "alpha")
Then, MCMC algorithm is run in three steps. Firstly, the JAGSmodel is compiled by means of the jags.model function
available from the rjags package:
R> library(rjags)
R> m1 <- jags.model(data=d.jags, file="AFT.txt", inits=i.jags, n.chains=3)
The n.chains argument indicates the number of Markov chains selected. Secondly, a burn-in period is considered (here
the first 1000 simulations) using the update function:
R> update(m1, 1000)
Thirdly, the model is run using coda.samples function for a specific number of iterations to monitor (here n.iter=10000)
as well as a specific thinning value (here thin=10) in order to reduce autocorrelation in the saved samples:
R> res <- coda.samples(m1, variable.names=p.jags, n.iter=10000, thin=10)
A posterior distributions summary can be obtained through the summary function:
R> summary(res)
Iterations = 2010:12000
Thinning interval = 10
Number of chains = 3
Sample size per chain = 1000
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Figure 1: Trace plots for α and β’s of the AFT model (8).
1. Empirical mean and standard deviation for each variable, plus standard error of the mean:
Mean SD Naive SE Time-series SE
alpha 0.99691 0.1356 0.002475 0.003014
beta[1] 2.58990 0.3106 0.005670 0.008864
beta[2] -0.13392 0.4948 0.009034 0.010425
beta[3] -0.66438 0.3832 0.006996 0.009668
beta[4] -1.68587 0.4705 0.008590 0.011483
beta[5] -0.22196 0.1633 0.002981 0.002981
beta[6] 0.07831 0.1686 0.003078 0.003562
2. Quantiles for each variable:
2.5% 25% 50% 75% 97.5%
alpha 0.7565 0.90070 0.99327 1.0843 1.27436
beta[1] 2.0475 2.36672 2.55959 2.7944 3.25784
beta[2] -1.1152 -0.46012 -0.14438 0.1802 0.85744
beta[3] -1.4447 -0.91461 -0.65398 -0.3972 0.05812
beta[4] -2.6318 -1.98983 -1.66538 -1.3739 -0.79131
beta[5] -0.5576 -0.32627 -0.21825 -0.1143 0.08240
beta[6] -0.2447 -0.03468 0.07615 0.1839 0.42431
Markov chains must reach stationarity and, to check this condition, several convergence diagnostics can be applied. Trace
plots (traceplot function) and the calculation of the Gelman-Rubin diagnostic (gelman.diag function) are used for
illustrating this issue (Gelman and Rubin, 1992; Brooks and Gelman, 1998) through the coda R-package (Plummer et al.,
2019):
R> library(coda); par(mfrow=c(2,4))
R> traceplot(res)
R> library(coda)
R> gelman.diag(res)
Potential scale reduction factors:
Point est. Upper C.I.
alpha 1.00 1.00
beta[1] 1.01 1.03
beta[2] 1.00 1.01
beta[3] 1.01 1.01
beta[4] 1.01 1.02
beta[5] 1.00 1.00
beta[6] 1.00 1.00
Multivariate psrf
1.01
Trace plots of the sampled values for each parameter in the chain appear overlapping one another and Gelman-Rubin
values are very close to 1, which indicates that convergence has been achieved.
From the densplot function, also available from the coda R-package, we can draw the marginal posterior distributions
(using kernel smoothing) for all the model parameters:
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Figure 2: Density plots for α and β’s of the AFT model (8).
R> library(coda); par(mfrow=c(2,4))
R> densplot(res)
Simulation-based Bayesian inference requires using simulated samples to summarise posterior distributions or calculate
any relevant quantities of interest. So, posterior samples from the three Markov chains can be merged together using the
following code:
R> library(coda)
R> result <- as.mcmc(do.call(rbind, res))
Next, the posterior samples of each parameter are extracted from the result object as follows:
R> alpha <- result[,1]; beta1 <- result[,2]; beta2 <- result[,3]; beta3 <- result[,4]
R> beta4 <- result[,5]; beta5 <- result[,6]; beta6 <- result[,7]
A relevant quantity for AFT models is the relative median (RM) between two individuals with covariate vectors x1 and
x2. This measure compares the median of the survival time between both individuals and is defined as:
RM(x1,x2,β) = exp
{
(x1 − x2)>β
}
.
As an illustration, we can easily summarise the posterior distribution of the RM between two men of the same age and
diagyr (year of diagnosis) but one in stage=3 and the other in stage=4:
R> RM.s3_s4 <- exp(beta3 - beta4)
R> summary(RM.s3_s4)
Iterations = 1:3000
Thinning interval = 1
Number of chains = 1
Sample size per chain = 3000
1. Empirical mean and standard deviation for each variable, plus standard error of the mean:
Mean SD Naive SE Time-series SE
3.06930 1.50830 0.02754 0.02898
2. Quantiles for each variable:
2.5% 25% 50% 75% 97.5%
1.183 2.061 2.743 3.700 6.731
Other Bayesian inference options for AFT models can be found in some R-packages. In particular, we highlight the
bayesSurv (Koma´rek, 2018) that provides implementations of mixed-effects AFT models with various censored data spec-
ifications; the DPpackage (Jara et al., 2018) that offers nonparametric and semiparametric models with different prior
processes; and spBayesSurv (Zhou and Hanson, 2018) that includes AFT and PH models (among others) for spatial/non-
spatial survival data.
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3.2 Proportional hazards models
3.2.1 Model specification
The proportional hazards (PH) model implemented in this section is also illustrated with the larynx dataset (see Section 3.1).
Survival time for each individual is modelled by means of the hazard function h(t) (see Section 2.1):
h(t | h0,β) = h0(t) exp
{
x>β
}
, (9)
where the baseline hazard function is defined with a Weibull specification, i.e., h0(t) = λα tα−1, where α and λ = exp(β1)
are shape and scale parameters, respectively (Klein and Moeschberger, 2003); and x>β = β21(stage=2) + β31(stage=3) +
β41(stage=4) + β5age + β6diagyr. We assume prior independence and specify prior marginal based on non-informative
distributions commonly employed in the literature. The β’s follow a N(0,0.001) and α a Gamma(0.01,0.01).
There is an equivalence between AFT (8) and PH (9) models in relation to regression parameters (Christensen et al., 2011),
where −α(a)β(a) = β(p) with superindices (a) and (p) denoting AFT and PH parameters, respectively.
3.2.2 Model definition
The variables time, cens, is.censored, age, diagyr, stage, and X are defined as in Section 3.1. Listing 2 shows a
generic implementation of a PH model in BUGS syntax using the larynx data.
Listing 2: PH model in BUGS syntax (file named as PH.txt).
1 model{
2 f o r ( i i n 1 : n ){
3 # S u r v i v a l and c e n s o r i n g t i m e s
4 i s . c e n s o r e d [ i ] ˜ d i n t e r v a l ( t ime [ i ] , c ens [ i ] )
5 t ime [ i ] ˜ dweib ( a lpha , l b d [ i ] )
6 l o g ( l b d [ i ] ) <- i n p r o d ( b e t a [ ] ,X[ i , ] )
7 }
8
9 # P r i o r d i s t r i b u t i o n s
10 f o r ( l i n 1 : Nbe tas ){ b e t a [ l ] ˜ dnorm ( 0 , 0 . 0 0 1 ) }
11 a l p h a ˜ dgamma ( 0 . 0 1 , 0 . 0 1 )
12
13 # Der ived q u a n t i t y
14 lambda <- exp ( b e t a [ 1 ] )
15 }
3.2.3 Model estimation: JAGS from R
Once the variables have been defined, a list with all the elements required in the model is created:
R> d.jags <- list(n=nrow(larynx), time=larynx$time, cens=cens, X=X,
+ is.censored=is.censored, Nbetas=ncol(X))
The initial values for each of the parameters in the PH model are passed to JAGS using a function that returns a list of
random values:
R> i.jags <- function(){ list(beta=rnorm(ncol(X)), alpha=runif(1)) }
The vector of monitored/saved parameters is:
R> p.jags <- c("beta", "alpha", "lambda")
Next, the JAGS model is compiled:
R> library(rjags)
R> m2 <- jags.model(data=d.jags, file="PH.txt", inits=i.jags, n.chains=3)
We now run the model for 1000 burn-in simulations:
R> update(m2, 1000)
Finally, the model is run for 10000 additional simulations to keep one in 10 so that a proper thinning is done:
R> res <- coda.samples(m2, variable.names=p.jags, n.iter=10000, n.thin=10)
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Similarly to the first example (Section 3.1), numerical and graphical summaries of the model parameters can be obtained
using the summary and densplot functions, respectively. Gelman and Rubin’s convergence diagnostic can be calculated
with the gelman.diag function, and the traceplot function provides a visual way to inspect sampling behaviour and
assesses mixing across chains and convergence.
Next, simulations from the three Markov chains are merged together for inference:
R> library(coda)
R> result <- as.mcmc(do.call(rbind, res))
The posterior samples of each parameter are obtained by:
R> alpha <- result[,1]; beta2 <- result[,3]; beta3 <- result[,4]; beta4 <- result[,5]
R> beta5 <- result[,6]; beta6 <- result[,7]; lambda <- result[,8]
Table 1 shows posterior summaries for the PH model parameters using the larynx data.
Table 1: Posterior summaries for the PH model parameters.
Parameter Mean SD 2.5% 50% 97.5% P (· > 0 | data)
β2 (stage=2) 0.119 0.481 -0.864 0.138 1.011 0.614
β3 (stage=3) 0.665 0.356 -0.017 0.672 1.378 0.972
β4 (stage=4) 1.751 0.426 0.955 1.750 2.587 1.000
β5 (age) 0.218 0.159 -0.091 0.215 0.542 0.919
β6 (diagyr) -0.047 0.163 -0.375 -0.048 0.274 0.380
α 1.118 0.140 0.863 1.109 1.411 –
λ 0.067 0.024 0.031 0.064 0.124 –
A relevant quantity for PH models is the hazard ratio (HR), also called relative risk, between two individuals with covariate
vectors x1 and x2. This measure is defined as:
HR(x1,x2, h0,β) =
h(t | x1, h0,β)
h(t | x2, h0,β) = exp
{
(x1 − x2)>β
}
,
and it is time independent. As an illustration, we can easily summarise the posterior distribution of the HR between two men
of the same age and diagyr (year of diagnosis) but one in stage=3 and the other in stage=4:
R> HR.s3_s4 <- exp(beta3 - beta4)
R> summary(HR.s3_s4)
Iterations = 1:3000
Thinning interval = 1
Number of chains = 1
Sample size per chain = 3000
1. Empirical mean and standard deviation for each variable, plus standard error of the mean:
Mean SD Naive SE Time-series SE
0.368779 0.161599 0.002950 0.003056
2. Quantiles for each variable:
2.5% 25% 50% 75% 97.5%
0.1467 0.2557 0.3370 0.4490 0.7723
Other Bayesian inference options for PH models can be found in some R-packages. In particular, we highlight the
BMA (Raftery et al., 2018) that implements a Bayesian model averaging approach for Cox proportional hazards models; the
dynsurv (Wang et al., 2017) that provides time-varying coefficient models for interval censored and right censored survival
data; the ICBayes (Pan et al., 2017) that offers semiparametric regression survival models to interval-censored time-to-event
data; and the spatsurv (Taylor et al., 2018) that provides parametric proportional hazards spatial survival models.
3.3 Mixture cure models
The illustration of a mixture cure model is based on a bone marrow transplant dataset, referred to as bmt, that is available from
the smcure R-package (Cai et al., 2012):
R> library(smcure)
R> data(bmt)
R> head(bmt)
Time Status TRT
1 11 1 0
10
2 14 1 0
3 23 1 0
4 31 1 0
5 32 1 0
6 35 1 0
This dataset refers to a bone marrow transplant study for the refractory acute lymphoblastic leukemia patients, in which 90
patients were divided into two treatment groups (Kersey et al., 1987). The following variables were observed for each patient:
• Time: time to death (in days).
• Status: censoring indicator (1: if patient is uncensored; 0: otherwise).
• TRT: treatment group indicator (0: allogeneic; 1: autologous).
3.3.1 Model specification
The (cure subpopulation) incidence model for each individual is expressed in terms of a logistic regression (see Section 2.2):
logit(η) = logit
[
η(βC1, βC2)
]
= βC1 + βC2TRT, (10)
where βC1 represents an intercept and βC2 is the regression coefficient for the TRT covariate.
Survival time for each individual in uncured subpopulation is modelled from a Weibull proportional hazard specification
(see Section 2.2):
hu(t | βU , λ, α) = λα tα−1 exp {βUTRT} , (11)
where α and λ are the shape and scale Weibull parameters, respectively; and βU is the regression coefficient for the TRT
covariate.
We assume prior independence and specify prior marginal based on non-informative distributions commonly employed in
the literature. The β’s follow a N(0,0.001); and the λ and the α a Gamma(0.01,0.01).
The likelihood function of this model can be expressed as (La´zaro et al., 2019):
L(θ | data) =
n∏
i=1
[
(1− η)fu(ti | θ)
]δ[
η + (1− η)Su(ti | θ)
]1−δ
, (12)
where θ = (βC1, βC2, βU , λ, α)>; fu is the uncured subpopulation density function and Su its respective survival function;
and δ represents a not censoring indicator, i.e., δ = Status.
The likelihood function (12) is not implemented in JAGS, so the “zeros trick” approach using a Poisson distribution has
been used to indirectly specify it (Ntzoufras, 2009; Lunn et al., 2012).
3.3.2 Model definition
We have created two design matrices, one for model (10) and another for model (11), with the TRT covariate:
R> XC <- model.matrix(˜ TRT, data=bmt) # Reference = allogeneic
R> XU <- matrix(model.matrix(˜ TRT, data=bmt)[,-1], ncol=1)
Listing 3 shows a generic implementation of a mixture cure model in BUGS syntax using the bmt data.
3.3.3 Model estimation: JAGS from R
Once the variables have been defined, a list with all the elements required in the model is created:
R> d.jags <- list(n=nrow(bmt), t=bmt$Time/(0.1*max(bmt$Time)), XC=XC, XU=XU,
+ delta=bmt$Status, zeros=rep(0,nrow(bmt)), NbetasC=ncol(XC), NbetasU=ncol(XU))
The initial values for each of the parameters in the competing risks model are passed to JAGS using a function that returns
a list of random values:
R> i.jags <- function(){ list(betaC=rnorm(ncol(XC)), betaU=rnorm(ncol(XU)),
+ lambda=runif(1), alpha=runif(1)) }
The vector of monitored/saved parameters is:
R> p.jags <- c("betaC", "betaU", "alpha", "lambda")
Next, the JAGS model is compiled:
R> library(rjags)
R> m3 <- jags.model(data=d.jags, file="Cure.txt", inits=i.jags, n.chains=3)
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Listing 3: Mixture cure model in BUGS syntax (file named as Cure.txt).
1 model{
2 f o r ( i i n 1 : n ){
3 # L o g i s t i c r e g r e s s i o n model ( c u r e d s u b p o p u l a t i o n )
4 l o g i t ( e t a [ i ] ) <- i n p r o d ( be taC [ ] ,XC[ i , ] )
5
6 # PH model ( uncu red s u b p o p u l a t i o n )
7 # Weibu l l b a s e l i n e
8 base [ i ] <- lambda∗ a l p h a ∗pow ( t [ i ] , a l p h a - 1 )
9 e l i n p r e d [ i ] <- exp ( i n p r o d ( betaU [ ] ,XU[ i , ] ) )
10 # Hazard f u n c t i o n
11 h [ i ] <- ba se [ i ]∗ e l i n p r e d [ i ]
12 # Log - s u r v i v a l f u n c t i o n
13 l o g s u r v [ i ] <- - lambda∗pow ( t [ i ] , a l p h a )∗ e l i n p r e d [ i ]
14
15 # D e f i n i t i o n o f t h e l o g - l i k e l i h o o d u s i n g z e r o s t r i c k
16 l o g L i k e [ i ] <- d e l t a [ i ] ∗ ( l o g (1 - e t a [ i ] ) + l o g ( h [ i ] ) + l o g s u r v [ i ] ) +
17 (1 - d e l t a [ i ] ) ∗ l o g ( e t a [ i ] + ( 1 - e t a [ i ] ) ∗ exp ( l o g s u r v [ i ] ) )
18 p h i [ i ] <- 100000 - l o g L i k e [ i ]
19 z e r o s [ i ] ˜ d p o i s ( p h i [ i ] )
20 }
21
22 # P r i o r d i s t r i b u t i o n s
23 f o r ( l i n 1 : NbetasC ){ betaC [ l ] ˜ dnorm ( 0 , 0 . 0 0 1 ) }
24 f o r ( l i n 1 : NbetasU ){ betaU [ l ] ˜ dnorm ( 0 , 0 . 0 0 1 ) }
25 lambda ˜ dgamma ( 0 . 0 1 , 0 . 0 1 )
26 a l p h a ˜ dgamma ( 0 . 0 1 , 0 . 0 1 )
27 }
We now run the model for 10000 burn-in simulations:
R> update(m3, 10000)
Finally, the model is run for 100000 additional simulations to keep one in 100 so that a proper thinning is done:
R> res <- coda.samples(m3, variable.names=p.jags, n.iter=100000, n.thin=100)
Similarly to the first example (Section 3.1), numerical and graphical summaries of the model parameters can be obtained
using the summary and densplot functions, respectively. Gelman and Rubin’s convergence diagnostic can be calculated
with the gelman.diag function, and the traceplot function provides a visual way to inspect sampling behaviour and
assesses mixing across chains and convergence.
Next, simulations from the three Markov chains are merged together for inference:
R> library(coda)
R> result <- as.mcmc(do.call(rbind, res))
The posterior samples of each parameter are obtained by:
R> alpha <- result[,1]; betaC1 <- result[,2]; betaC2 <- result[,3]
R> betaU <- result[,4]; lambda <- result[,5]
Table 2 shows posterior summaries for the mixture cure model parameters using the bmt data.
Table 2: Posterior summaries for the mixture cure model parameters.
Parameter Mean SD 2.5% 50% 97.5% P (· > 0 | data)
βC1 (intercept) -1.015 0.349 -1.736 -1.004 -0.361 0.001
βC2 (TRT) -0.419 0.517 -1.446 -0.416 0.587 0.207
βU (TRT) 0.759 0.269 0.237 0.757 1.293 0.998
α 1.135 0.104 0.935 1.134 1.342 –
λ 0.652 0.134 0.417 0.643 0.941 –
A relevant quantity for mixture cure models is the cure fraction (η), here for allogeneic (TRT=0) autologous and (TRT=1)
treated patients. This measure is defined as:
η(TRT, βC1, βC2) =
exp(βC1 + βC2TRT)
1 + exp(βC1 + βC2TRT)
.
We can easily summarise the posterior distribution of the cure fraction of individuals in both groups:
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Figure 3: Posterior mean of the uncured survival function from the mixture cure model (11).
R> eta.allo <- exp(betaC1)/(1+exp(betaC1))
R> eta.auto <- exp(betaC1+betaC2)/(1+exp(betaC1+betaC2))
R> summary(cbind(eta.allo, eta.auto))
eta.allo eta.auto
Min. :0.01708 Min. :0.02999
1st Qu.:0.22447 1st Qu.:0.15671
Median :0.26814 Median :0.19473
Mean :0.27141 Mean :0.19922
3rd Qu.:0.31515 3rd Qu.:0.23677
Max. :0.61886 Max. :0.54163
The uncured survival curve based on posterior samples is another relevant information in this type of study. So, from the
posterior samples obtained above, we can summarise the posterior distribution of the mean value of the uncured survival curve
for allogeneic and autologous treated patients in a grid of points as follows:
R> grid <- 100; time <- seq(0, 10, len=grid); surv.allo <- surv.auto <- vector()
R> for(l in 1:grid){
+ surv.allo[l] <- mean(exp(-lambda*time[l]ˆalpha))
+ surv.auto[l] <- mean(exp(-lambda*exp(betaU)*time[l]ˆalpha))
+}
Figure 3 shows the difference between both curves using the code below:
R> library(ggplot2)
R> treat.col <- rep(0:1, each=grid)
R> treat.col[treat.col == 0] <- "allogeneic"; treat.col[treat.col == 1] <- "autologous"
R> df <- data.frame(time=rep(time,2), survival=c(surv.allo,surv.auto), treatment=treat.col)
R> ggplot(data=df, aes(x=time, y=survival, group=treatment, colour=treatment)) +
+ geom_line() + theme(legend.position=c(0.9,0.9))
3.4 Competing risks models
The illustration of a competing risks model is based on a stem-cell transplanted patients data, referred to as okiss, that is
available from the compeir R-package (Grambauer and Neudecker, 2011):
R> library(compeir)
R> data(okiss)
R> head(okiss)
time status allo sex
411 21 2 1 f
1031 6 1 1 f
1545 14 2 1 f
892 12 2 1 m
1585 11 2 1 m
824 18 2 1 m
This dataset provides information about a sub-sample of 1000 patients enrolled in the ONKO-KISS programme, which
is part of the German National Reference Centre for Surveillance of Hospital-Acquired Infections (Dettenkofer et al., 2005).
These patients have been treated by peripheral blood stem-cell transplantation, which has become a successful therapy for
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severe hematologic diseases. After transplantation, patients are neutropenic, i.e., they have a low count of white blood cells,
which are the cells that primarily avert infections (Beyersmann et al., 2007). Occurrence of bloodstream infection during
neutropenia is a severe complication. The following variables were observed for each patient:
• time: time (in days) of neutropenia until first event.
• status: event status indicator (1: infection; 2: end of neutropenia; 7: death; 11: censored observation).
• allo: transplant type indicator (0: autologous; 1: allogeneic).
• sex: sex of each patient (m: if patient is male; f: if patient is female).
We have redefined the status variable using an auxiliary one (delta) in a matrix format:
R> delta <- matrix(c(as.integer(okiss$status == 1), as.integer(okiss$status == 2),
+ as.integer(okiss$status == 7)), ncol=3)
R> head(delta)
[,1] [,2] [,3]
[1,] 0 1 0
[2,] 1 0 0
[3,] 0 1 0
[4,] 0 1 0
[5,] 0 1 0
[6,] 0 1 0
where the events 1 (infection), 2 (end of neutropenia) and 7 (death) are indicated with a value of 1 in column 1, 2 or 3,
respectively, and a row with only 0’s represents a censored observation.
3.4.1 Model specification
Cause-specific hazard functions are modelled from a Weibull proportional hazard specification (see Section 2.3):
hk(t | β, λk, αk) = λk αk tαk−1 exp {β1kallo + β2ksex} , k = 1, 2, 3, (13)
where αk and λk are the shape and scale Weibull parameters, respectively, for event k; and β1k and β2k are regression
coefficients for the allo and sex covariates, respectively, for k = 1, 2, 3. We assume prior independence and specify prior
marginal based on non-informative distributions commonly employed in the literature. The β’s follow a N(0,0.001); and the
λ’s and the α’s a Gamma(0.01,0.01).
3.4.2 Model definition
We have created a design matrix X with the covariates allo and sex:
R> X <- model.matrix(˜ allo + sex, data=okiss)[,-1] # Reference = female
Listing 4 shows a generic implementation of a competing risks model in BUGS syntax using the okiss data.
3.4.3 Model estimation: JAGS from R
Once the variables have been defined, a list with all the elements required in the model is created:
R> d.jags <- list(n=nrow(okiss), t=as.vector(okiss$time)/(0.1*max(okiss$time)), X=X,
+ delta=delta, zeros=rep(0,nrow(okiss)), Nbetas=ncol(X), Nrisks=ncol(delta))
The initial values for each of the parameters in the competing risks model are passed to JAGS using a function that returns
a list of random values:
R> i.jags <- function(){ list(beta=matrix(rnorm(ncol(X)*ncol(delta)), ncol=ncol(delta)),
+ lambda=runif(ncol(delta)), alpha=runif(ncol(delta))) }
The vector of monitored/saved parameters is:
R> p.jags <- c("beta", "alpha", "lambda")
Next, the JAGS model is compiled:
R> library(rjags)
R> m4 <- jags.model(data=d.jags, file="CR.txt", inits=i.jags, n.chains=3)
We now run the model for 1000 burn-in simulations:
R> update(m4, 1000)
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Listing 4: Competing risks model in BUGS syntax (file named as CR.txt).
1 model{
2 f o r ( i i n 1 : n ){
3 f o r ( k i n 1 : N r i s k s ){
4 # Weibu l l b a s e l i n e
5 base [ i , k ] <- lambda [ k ]∗ a l p h a [ k ]∗pow ( t [ i ] , a l p h a [ k ] - 1 )
6 e l i n p r e d [ i , k ] <- exp ( i n p r o d ( b e t a [ , k ] ,X[ i , ] ) )
7 # Hazard f u n c t i o n s
8 h [ i , k ] <- ba se [ i , k ]∗ e l i n p r e d [ i , k ]
9 # Log - s u r v i v a l f u n c t i o n s
10 l o g s u r v [ i , k ] <- - lambda [ k ]∗pow ( t [ i ] , a l p h a [ k ] ) ∗ e l i n p r e d [ i , k ]
11 }
12
13 # D e f i n i t i o n o f t h e l o g - l i k e l i h o o d u s i n g z e r o s t r i c k
14 l o g L i k e [ i ] <- i n p r o d ( d e l t a [ i , ] , l o g ( h [ i , ] ) ) + sum ( l o g s u r v [ i , ] )
15 p h i [ i ] <- 100000 - l o g L i k e [ i ]
16 z e r o s [ i ] ˜ d p o i s ( p h i [ i ] )
17 }
18
19 # P r i o r d i s t r i b u t i o n s
20 f o r ( k i n 1 : N r i s k s ){
21 f o r ( l i n 1 : Nbe tas ){ b e t a [ l , k ] ˜ dnorm ( 0 , 0 . 0 0 1 ) }
22 lambda [ k ] ˜ dgamma ( 0 . 0 1 , 0 . 0 1 )
23 a l p h a [ k ] ˜ dgamma ( 0 . 0 1 , 0 . 0 1 )
24 }
25 }
Finally, the model is run for 10000 additional simulations to keep one in 10 so that a proper thinning is done:
R> res <- coda.samples(m4, variable.names=p.jags, n.iter=10000, n.thin=10)
Similarly to the first example (Section 3.1), numerical and graphical summaries of the model parameters can be obtained
using the summary and densplot functions, respectively. Gelman and Rubin’s convergence diagnostic can be calculated
with the gelman.diag function, and the traceplot function provides a visual way to inspect sampling behaviour and
assesses mixing across chains and convergence.
Next, simulations from the three Markov chains are merged together for inference:
R> library(coda)
R> result <- as.mcmc(do.call(rbind, res))
The posterior samples of each parameter are obtained by:
R> alpha1 <- result[,1]; alpha2 <- result[,2]; alpha3 <- result[,3]; beta11 <- result[,4]
R> beta21 <- result[,5]; beta12 <- result[,6]; beta22 <- result[,7]; beta13 <- result[,8]
R> beta23 <- result[,9]; lambda1 <- result[,10]; lambda2 <- result[,11]; lambda3 <- result[,12]
Table 3 shows posterior summaries for the competing risks model parameters using the okiss data.
As discussed in Section 2.3, the cumulative incidence function (CIF), Fk(t) (see Equation 5), is the most appropriate way
to analyse the evolution of each cause k over time. For our Weibull specification, the CIF is given by:
Fk(t) =
∫ t
0
λk αk u
αk−1 exp
{
x>βk
}
exp
{
−
3∑
l=1
λl u
αl exp
{
x>βl
}}
du, (14)
where x>βk = β1kallo + β2ksex, for k = 1, 2, 3.
The integral in (14) has no closed form, so some approximate method of integration is required. To do this, we first have
created a function ff which describes the integrand of (14):
R> ff <- function(u.vect, lambda, alpha, beta, x, idx){
+ res <- sapply(u.vect, function(u){
+ # Cause-specific hazard
+ hk <- lambda[idx]*alpha[idx]*(uˆ(alpha[idx]-1)) * exp(sum(unlist(beta[,idx])*x))
+ # Cumulative cause-specific hazard
+ Hk <- lambda*(rep(u,length(lambda))ˆalpha) * exp((t(beta)%*%matrix(x, ncol=1))[,1])
+ # Cause-specific hazard x Overall survival
+ aux <- hk * exp(-sum(Hk))
+ return(aux)
+ })
+ return(res) }
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Table 3: Posterior summaries for the competing risks model parameters.
Parameter Mean SD 2.5% 50% 97.5% P (· > 0 | data)
Infection (k = 1)
β11 (allo) -0.519 0.150 -0.814 -0.520 -0.221 0.000
β21 (sex) 0.154 0.148 -0.136 0.152 0.446 0.850
λ1 0.162 0.024 0.119 0.160 0.212 –
α1 1.131 0.067 1.004 1.130 1.266 –
End of neutropenia (k = 2)
β12 (allo) -1.195 0.076 -1.345 -1.194 -1.045 0.000
β22 (sex) -0.100 0.074 -0.242 -0.101 0.046 0.092
λ2 0.573 0.042 0.493 0.572 0.659 –
α2 2.032 0.044 1.946 2.032 2.119 –
Death (k = 3)
β13 (allo) -0.568 0.738 -1.949 -0.593 0.951 0.213
β23 (sex) 0.497 0.739 -0.844 0.461 2.041 0.742
λ3 0.002 0.002 0.000 0.002 0.008 –
α3 2.559 0.411 1.764 2.549 3.391 –
Next, we have created a function cif that computes Fk(t) in (14) by integrating out the ff using the integral function
available from the pracma R-package (Borchers, 2019).
R> library(pracma)
R> cif <- function(tt, lambda, alpha, beta, x, idx){
+ return(integral(ff, xmin=0, xmax=tt, method="Simpson", lambda=lambda, alpha=alpha,
+ beta=beta, x=x, idx=idx)) }
Finally, we have created a function mcmc cif that takes the output from JAGS (variable obj) and computes Fk(t) in
(14) for a vector of times (variable t.pred) using covariates x. Note that mcmc cif is based on the mclapply function,
available from the parallel R-package, to speed computations up.
R> library(parallel)
R> options(mc.cores=detectCores())
R> mcmc_cif <- function(obj, t.pred, x){
+ var.names <- names(obj)
+ # Indices of beta’s, alpha’s, and lambda’s
+ b.idx <- which(substr(var.names,1,4) == "beta")
+ a.idx <- which(substr(var.names,1,5) == "alpha")
+ l.idx <- which(substr(var.names,1,6) == "lambda")
+ # Number of causes and number of covariates
+ K <- length(a.idx); n.b <- length(b.idx)/K
+ # Sub-sample to speed up computations
+ samples.idx <- sample(1:nrow(obj),200)
+
+ res <- lapply(1:K, function(cc){
+ sapply(t.pred, function(tt){
+ aux <- mclapply(samples.idx, function(i){
+ cif(tt, alpha=unlist(obj[i,a.idx]), lambda=unlist(obj[i,l.idx]),
+ beta=matrix(unlist(c(res[i,b.idx])), nrow=n.b), x=x, idx=cc)
+ })
+ return(mean(unlist(aux)))
+ })
+ })
+ return(res) }
Hence, we redefine the MCMC output as a simple data.frame and set a vector of times to evaluate the cumulative
incidence function. In this example, we are interested in the CIF when both covariates are 1 (i.e., allogeneic transplant and
male).
R> res <- as.data.frame(result)
R> t.pred <- seq(0, 10, by=0.25)
R> cum_inc <- mcmc_cif(res, t.pred, c(1,1))
Figure 4, generated from the code below, shows the cumulative incidence functions of a man with an allogeneic transplant
for the three types of events considered in the okiss data.
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Figure 4: Posterior mean of the cumulative incidence function for allo=1 (allogeneic transplant) and sex=1 (male) from
the competing risks model (13).
R> library(ggplot2)
R> df <- data.frame(cif=unlist(cum_inc), time=t.pred,
+ cause=rep(c("infection","end of neutropenia","death"), each=length(t.pred)))
R> ggplot(data=df, aes(x=time, y=cif, group=cause)) + geom_line(aes(color=cause)) +
+ ylab("cumulative incidence") + theme(legend.position=c(0.1,0.8)) + ylim(c(0,1))
Other Bayesian inference options for competing risks models can be found in some R-packages. In particular, we highlight
the CFC (Sharabiani and Mahani, 2019) that implements a cause-specific framework for competing-risk analysis; and the
SemiCompRisks (Lee et al., 2019) that provides a broader specification using of independent/clustered semi-competing
risks models.
3.5 Frailty models
The illustration of a frailty model is based on a kidney infection dataset, referred to as kidney, that is available from the
frailtyHL R-package (Ha et al., 2018):
R> library(frailtyHL)
R> data(kidney)
R> head(kidney)
id time status age sex disease frail GN AN PKD
1 1 8 1 28 1 Other 2.3 0 0 0
2 1 16 1 28 1 Other 2.3 0 0 0
3 2 23 1 48 2 GN 1.9 1 0 0
4 2 13 0 48 2 GN 1.9 1 0 0
5 3 22 1 32 1 Other 1.2 0 0 0
6 3 28 1 32 1 Other 1.2 0 0 0
This dataset consists of times to the first and second recurrences of infection in 38 kidney patients using a portable dialysis
machine. Infections can occur at the location of insertion of the catheter. The catheter is later removed if infection occurs and
can be removed for other reasons, in which case the observation is censored (McGilchrist and Aisbett, 1991). The following
variables were observed twice for each patient:
• id: patient number.
• time: time (in days) from insertion of the catheter to infection in kidney patients using portable dialysis machine.
• status: censoring indicator (1: if patient is uncensored; 0: otherwise).
• age: age (in years) of each patient.
• sex: sex of each patient (1: if patient is male; 2: if patient is female).
• disease: disease type (GN; AN; PKD; Other).
• frail: frailty estimate from original paper.
• GN: indicator for disease type GN.
• AN: indicator for disease type AN.
• PKD: indicator for disease type PKD.
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3.5.1 Model specification
Survival time for each individual in uncured subpopulation is modelled from a Weibull proportional hazard specification with
multiplicative frailties (see Section 2.4):
h(t | β, λ, α, w) = wλα tα−1 exp {β2sex} , (15)
where w ∼ Gamma(ψ,ψ) is the frailty term for each individual; α and λ = exp(β1) are the shape and scale Weibull
parameters, respectively; and β2 is the regression coefficient for the sex covariate. As the purpose of this modelling is
illustrative, the other covariates will not be considered. We assume prior independence and specify prior marginal based on
non-informative distributions commonly employed in the literature. The β’s follow a N(0,0.001); and the α and the ψ a
Gamma(0.01,0.01).
3.5.2 Model definition
Our variable of interest is time, which represents the time from insertion of the jth catheter to infection, j = 1, . . . , J = 2.
The status covariate plays an important role in the codification of the survival and censoring times:
R> # Number of patients and catheters
R> n <- length(unique(kidney$id)); J <- 2
R> # Survival and censoring times
R> time <- kidney$time/(0.1*max(kidney$time)); cens <- time
R> time[kidney$status == 0] <- NA # Censored
R> cens[kidney$status == 1] <- 0 # Uncensored
R> is.censored <- as.numeric(is.na(time))
R> # Matrix format
R> time <- matrix(time, n, J, byrow=TRUE); cens <- matrix(cens, n, J, byrow=TRUE)
R> is.censored <- matrix(is.censored, n, J, byrow=TRUE)
Without loss of generality, we have created a design matrix X with the sex covariate:
R> sex <- kidney$sex[seq(1, 2*n, 2)] - 1 # Reference = male
R> X <- model.matrix(˜ sex)
Listing 5 shows a generic implementation of a frailty model in BUGS syntax using the kidney data.
Listing 5: Frailty model in BUGS syntax (file named as Frailty.txt).
1 model{
2 f o r ( i i n 1 : n ){
3 f o r ( j i n 1 : J ){
4 # S u r v i v a l and c e n s o r i n g t i m e s
5 i s . c e n s o r e d [ i , j ] ˜ d i n t e r v a l ( t ime [ i , j ] , c ens [ i , j ] )
6 t ime [ i , j ] ˜ dweib ( a lpha , l b d [ i , j ] )
7 l o g ( l b d [ i , j ] ) <- i n p r o d ( b e t a [ ] ,X[ i , ] ) + l o g (w[ i ] )
8 }
9 # M u l t i p l i c a t i v e f r a i l t i e s
10 w[ i ] ˜ dgamma ( p s i , p s i )
11 }
12
13 # P r i o r d i s t r i b u t i o n s
14 f o r ( l i n 1 : Nbe tas ){ b e t a [ l ] ˜ dnorm ( 0 . 0 , 0 . 0 0 1 ) }
15 a l p h a ˜ dgamma ( 0 . 0 1 , 0 . 0 1 )
16 p s i ˜ dgamma ( 0 . 0 1 , 0 . 0 1 )
17
18 # Der ived q u a n t i t y
19 lambda <- exp ( b e t a [ 1 ] )
20 }
3.5.3 Model estimation: JAGS from R
Once the variables have been defined, a list with all the elements required in the model is created:
R> d.jags <- list(n=n, J=J, time=time, cens=cens, X=X, is.censored=is.censored, Nbetas=ncol(X))
The initial values for each of the parameters in the frailty model are passed to JAGS using a function that returns a list of
random values:
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R> i.jags <- function(){ list(beta=rnorm(ncol(X)), alpha=runif(1), psi=runif(1)) }
The vector of monitored/saved parameters is:
R> p.jags <- c("beta", "alpha", "lambda", "psi", "w")
Next, the JAGS model is compiled:
R> library(rjags)
R> m5 <- jags.model(data=d.jags, file="Frailty.txt", inits=i.jags, n.chains=3)
We now run the model for 10000 burn-in simulations:
R> update(m5, 10000)
Finally, the model is run for 100000 additional simulations to keep one in 100 so that a proper thinning is done:
R> res <- coda.samples(m5, variable.names=p.jags, n.iter=100000, thin=100)
Similarly to the first example (Section 3.1), numerical and graphical summaries of the model parameters can be obtained
using the summary and densplot functions, respectively. Gelman and Rubin’s convergence diagnostic can be calculated
with the gelman.diag function, and the traceplot function provides a visual way to inspect sampling behaviour and
assesses mixing across chains and convergence.
Next, simulations from the three Markov chains are merged together for inference:
R> library(coda)
R> result <- as.mcmc(do.call(rbind, res))
The posterior samples of each parameter are obtained by:
R> alpha <- result[,1]; beta2 <- result[,3]; lambda <- result[,4]
R> psi <- result[,5]; w <- result[,6:ncol(result)]
Table 4 shows posterior summaries for the frailty model parameters using the kidney data.
Table 4: Posterior summaries for the frailty model parameters.
Parameter Mean SD 2.5% 50% 97.5% P (· > 0 | data)
β2 (sex) -1.864 0.547 -3.028 -1.848 -0.889 0.000
α 1.212 0.158 0.917 1.205 1.533 –
λ 2.538 1.372 0.970 2.231 5.827 –
ψ 2.559 2.346 0.800 1.974 8.432 –
The individual survival curve based on posterior samples is relevant information in this type of study. So, we can sum-
marise the posterior distribution of the individual survival curve in a grid of points as follows:
R> grid <- 100
R> time <- seq(0, 10, len=grid)
R> surv <- matrix(NA, n, grid)
R> for(g in 1:n){
+ for(l in 1:grid){ surv[g,l] <- mean(exp(-w[g]*lambda*exp(beta2*sex[g])*time[l]ˆalpha)) }
+}
Next, we can differentiate the survival curves by sex (code below). Figure 5 shows such curves for all patients in the kidney
data.
R> library(ggplot2)
R> sex.col <- sex; sex.col[sex == 0] <- "male"; sex.col[sex == 1] <- "female"
R> df <- data.frame(time=rep(time,n), survival=c(t(surv)),
+ patient=rep(1:n,each=grid), sex=rep(sex.col,each=grid))
R> ggplot(data=df, aes(x=time, y=survival, group=patient, colour=sex)) +
+ geom_line() + theme(legend.position=c(0.9,0.9))
3.6 Joint models of longitudinal and survival data
The illustration of a joint model of longitudinal and survival data is based on a liver cirrhosis dataset, referred to as prothro
(long format) and prothros (short format), that is available from the JMbayes R-package (Rizopoulos, 2019):
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Figure 5: Posterior mean of the individual survival function from the frailty model (15).
R> library(JMbayes)
R> data(prothro); prothro[,-4] <- round(prothro[,-4], 6)
R> data(prothros); prothros[,-4] <- round(prothros[,-4], 6)
R> head(prothro); head(prothros)
id pro time treat Time start stop death event
1 1 38 0.000000 prednisone 0.413427 0.000000 0.243675 1 0
2 1 31 0.243675 prednisone 0.413427 0.243675 0.380572 1 0
3 1 27 0.380572 prednisone 0.413427 0.380572 0.413427 1 1
4 2 51 0.000000 prednisone 6.754463 0.000000 0.687219 1 0
5 2 73 0.687219 prednisone 6.754463 0.687219 0.961012 1 0
6 2 90 0.961012 prednisone 6.754463 0.961012 1.188260 1 0
id Time death treat
1 1 0.413427 1 prednisone
2 2 6.754463 1 prednisone
3 3 13.393933 0 prednisone
4 4 0.793998 1 prednisone
5 5 0.750192 1 prednisone
6 6 0.769357 1 prednisone
These datasets are part of a placebo-controlled randomised trial on 488 liver cirrhosis patients, where the longitudinal
observations of a biomarker (prothrombin) are recorded (Andersen et al., 1993). The following variables were observed for
each patient:
• id: patient number.
• pro: prothrombin measurements.
• time: time points at which the prothrombin measurements were taken.
• treat: randomised treatment (placebo or prednisone).
• Time: time (in years) from the start of treatment until death or censoring.
• death: censoring indicator (1: if patient is died; 0: otherwise).
3.6.1 Model specification
A mixed-effect model (Laird and Ware, 1982) is used to describe the subject-specific prothrombin evolution over time:
y(t) = βL1 + b1 + (βL2 + b2) t+ βL3treat + (t), (16)
where y(t) represents the prothrombin value at time t for each individual; βL1 and βL2 are fixed effects for intercept and
slope, respectively, with b1 and b2 being their respective individual random effects; βL3 is the regression coefficient for the
treat covariate; and (t) is a measurement error at time t for each individual. We assume that the individual random effects,
b = (b1, b2)
>, given Σ follow a joint bivariate normal distribution with mean vector (0, 0) and variance-covariance matrix
Σ, and that the errors are conditionally i.i.d. as ((t) | σ2) ∼ N(0, 1/σ2). Random effects and error terms were assumed
mutually independent.
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We assume prior independence and specify prior marginal based on non-informative distributions commonly employed in
the literature. The βL’s follow a N(0,0.001); σ follows a U(0,100); and Σ follows an Inv-Wishart(V ,2), where V is a 2×2
identity matrix.
Survival time for each individual is modelled from a Weibull proportional hazard specification. In addition, we assume
a shared-parameter approach (see Section 2.5), where the random effects of the longitudinal submodel are shared with the
survival submodel:
h(t | βS , λ, α, γ, b) = λα tα−1 exp {βS2treat + γ(b1 + b2t)} , (17)
where α and λ = exp(βS1) are the shape and scale Weibull parameters, respectively; βS2 is the regression coefficient for the
treat covariate; and γ is an association parameter that measure the strength of the association between the random effects
of the longitudinal submodel and the risk of death at time t.
We assume prior independence and specify prior marginal based on non-informative distributions commonly employed in
the literature. The βS’s and γ follow a N(0,0.001); and α a Gamma(0.01,0.01).
3.6.2 Model definition
Our variable of interest is Time (prothros file), which represents the time from the start of treatment until death or censoring.
The death=1 covariate indicates an uncensored time:
R> # Number of patients and number of longitudinal observations per patient
R> n <- dim(prothros)[1]; M <- as.numeric(table(prothro$id))
R> # Survival and censoring times
R> Time <- prothros$Time
R> death <- prothros$death
The (log)prothrombin observations and their respective measurement times (prothro file) have been rearranged in matrix
format:
R> # Longitudinal information in matrix format
R> time <- matrix(NA, n, max(M)); log.proth <- matrix(NA, n, max(M)); count <- 1
R> for(i in 1:n){
+ log.proth[i,1:M[i]] <- log(prothro$pro[count:(M[i] + count - 1)])
+ time[i,1:M[i]] <- prothro$time[count:(M[i] + count - 1)]
+ count <- count + M[i]
+}
We have created the survival design matrix composed of an intercept and a treatment variable:
R> treat <- as.numeric(prothros$treat) - 1 # Reference = placebo
R> XS <- model.matrix(˜ treat) # Fixed effects
We have split the longitudinal design matrix into two parts, XL (fixed effects) and ZL (random effects):
R> XL <- array(1, dim=c(n,max(M),3)) # Fixed effects
R> XL[,,2] <- time; XL[,,3] <- treat
R> ZL <- array(1, dim=c(n,max(M),2)) # Random effects
R> ZL[,,2] <- time
The survival function, S(t | βS , λ, α, γ, b) = exp
{
− ∫ t
0
h(u | βS , λ, α, γ, b) du
}
, has no closed-form. However, by
definition, this integral is always one-dimensional, and it can be efficiently approximated using some Gaussian quadrature
method, available from the statmod R-package (Smyth et al., 2020). For our analysis, we have used 15-point Gauss-
Legendre quadrature rule, as is done in Armero et al. (2018):
R> # Gauss-Legendre quadrature (15 points)
R> library(statmod)
R> glq <- gauss.quad(15, kind="legendre")
R> xk <- glq$nodes # Nodes
R> wk <- glq$weights # Weights
R> K <- length(xk) # K-points
Listing 6 shows a generic implementation of a joint model in BUGS syntax using the prothro/prothros data.
3.6.3 Model estimation: JAGS from R
Once the variables have been defined, a list with all the elements required in the model is created:
R> d.jags <- list(n=n, M=M, Time=Time, XS=XS, log.proth=log.proth, XL=XL, ZL=ZL, death=death,
+ mub=rep(0,2), V=diag(1,2), Nb=2, NbetasS=ncol(XS), NbetasL=dim(XL)[3],
+ K=length(xk), xk=xk, wk=wk)
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Listing 6: Joint model in BUGS syntax (file named as JM.txt).
1 model{
2 f o r ( i i n 1 : n ){
3 # L o n g i t u d i n a l o b s e r v a t i o n s
4 f o r ( j i n 1 :M[ i ] ) {
5 l o g . p r o t h [ i , j ] ˜ dnorm (mu[ i , j ] , t a u )
6 mu[ i , j ] <- i n p r o d ( be taL [ ] , XL[ i , j , ] ) + i n p r o d ( b [ i , ] , ZL [ i , j , ] )
7 }
8
9 # S u r v i v a l and c e n s o r i n g t i m e s
10 # Hazard f u n c t i o n a t i n t e g r a t i o n p o i n t s
11 f o r ( j i n 1 :K){
12 h [ i , j ] <- a l p h a ∗pow ( Time [ i ] / 2 ∗ ( xk [ j ] + 1 ) , a l p h a - 1 ) ∗
13 exp ( i n p r o d ( b e t a S [ ] , XS[ i , ] ) + gamma∗ ( b [ i , 1 ] + b [ i , 2 ] ∗ ( Time [ i ] / 2 ∗ ( xk [ j ] + 1 ) ) ) )
14 }
15 # Log - s u r v i v a l f u n c t i o n wi th Gauss - Legendre q u a d r a t u r e
16 l o g s u r v [ i ] <- - Time [ i ] / 2 ∗ i n p r o d ( wk , h [ i , ] )
17
18 # D e f i n i t i o n o f t h e s u r v i v a l l o g - l i k e l i h o o d u s i n g z e r o s t r i c k
19 l o g L i k e [ i ] <- d e a t h [ i ]∗ l o g ( h [ i ,K] ) + l o g s u r v [ i ]
20 p h i [ i ] <- 100000 - l o g L i k e [ i ]
21 z e r o s [ i ] ˜ d p o i s ( p h i [ i ] )
22
23 # Random e f f e c t s
24 b [ i , 1 : Nb ] ˜ dmnorm ( mub [ ] , Omega [ , ] )
25 }
26
27 # P r i o r d i s t r i b u t i o n s
28 f o r ( l i n 1 : NbetasS ){ b e t a S [ l ] ˜ dnorm ( 0 . 0 , 0 . 0 0 1 ) }
29 gamma ˜ dnorm ( 0 . 0 , 0 . 0 0 1 )
30 a l p h a ˜ dgamma ( 0 . 0 1 , 0 . 0 1 )
31 f o r ( l i n 1 : NbetasL ){ be taL [ l ] ˜ dnorm ( 0 . 0 , 0 . 0 0 1 ) }
32 t a u <- pow ( sigma , - 2 )
33 s igma ˜ d u n i f ( 0 , 1 0 0 )
34 Omega [ 1 : Nb , 1 : Nb ] ˜ dwish (V[ , ] , Nb )
35 Sigma [ 1 : Nb , 1 : Nb ] <- i n v e r s e ( Omega [ , ] )
36
37 # Der ived q u a n t i t y
38 lambda <- exp ( b e t a S [ 1 ] )
39 }
The variables mub and V represent, respectively, the mean of the random effects normally distributed and the scale matrix
of the Wishart distribution which models the precision of the random effects.
The initial values for each of the parameters in the joint model are passed to JAGS using a function that returns a list of
random values:
R> i.jags <- function(){
+ list(betaS=rnorm(ncol(XS)), gamma=rnorm(1), alpha=runif(1),
+ betaL=rnorm(dim(XL)[3]), sigma=runif(1), Omega=diag(runif(2))) }
The vector of monitored/saved parameters is:
R> p.jags <- c("betaS", "gamma", "alpha", "lambda", "betaL", "sigma", "Sigma", "b")
Next, the JAGS model is compiled:
R> library(rjags)
R> m6 <- jags.model(data=d.jags, file="JM.txt", inits=i.jags, n.chains=3)
We now run the model for 1000 burn-in simulations:
R> update(m6, 1000)
Finally, the model is run for 10000 additional simulations to keep one in 10 so that a proper thinning is done:
R> res <- coda.samples(m6, variable.names=p.jags, n.iter=10000, thin=10)
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Similarly to the first example (Section 3.1), numerical and graphical summaries of the model parameters can be obtained
using the summary and densplot functions, respectively. Gelman and Rubin’s convergence diagnostic can be calculated
with the gelman.diag function, and the traceplot function provides a visual way to inspect sampling behaviour and
assesses mixing across chains and convergence.
Next, simulations from the three Markov chains are merged together for inference:
R> library(coda)
R> result <- as.mcmc(do.call(rbind, res))
The posterior samples of each parameter are obtained by:
R> Sigma2.11 <- result[,1]; Sigma2.12 <- result[,2]; Sigma2.22 <- result[,4]
R> alpha <- result[,5]; b1 <- result[,6:(n+5)]; b2 <- result[,(n+6):(2*n+5)]
R> betaL1 <- result[,(2*n+6)]; betaL2 <- result[,(2*n+7)]; betaL3 <- result[,(2*n+8)]
R> betaS2 <- result[,(2*n+10)]; gamma <- result[,(2*n+11)]
R> lambda <- result[,(2*n+12)]; sigma <- result[,(2*n+13)]
Table 5 shows posterior summaries for the joint model parameters using the prothro/prothros data.
Table 5: Posterior summaries for the joint model parameters.
Parameter Mean SD 2.5% 50% 97.5% P (· > 0 | data)
βS2 (treat) 0.081 0.135 -0.193 0.082 0.346 0.728
γ (assoc) -2.268 0.180 -2.619 -2.266 -1.914 0.000
λ 0.187 0.023 0.147 0.186 0.234 –
α 0.928 0.051 0.833 0.927 1.028 –
βL1 (intercept) 4.277 0.021 4.235 4.276 4.317 1.000
βL2 (slope) -0.002 0.008 -0.018 -0.003 -0.015 0.384
βL3 (treat) -0.103 0.030 -0.160 -0.103 -0.044 0.000
σ 0.258 0.004 0.250 0.257 0.265 –
Σ11 0.099 0.008 0.083 0.099 0.115 –
Σ22 0.013 0.002 0.011 0.013 0.017 –
Σ12 -0.004 0.003 -0.010 -0.003 0.002 0.123
The most parameters are interpreted similarly to previous examples. However, the association parameter, γ, plays an
important role in this type of model. In our illustration, the posterior distribution of this parameter has only negative values,
P (γ > 0 | data) = 0, indicating strong negative association of the prothrombin measurements with respect to vital status.
Furthermore, a negative value for γ means that low values or decreasing trends of prothrombin increase the risk of death.
Another Bayesian inference option for joint models can be found in the R-package JMbayes (Rizopoulos, 2019), where
the longitudinal process is modelled through a linear mixed framework, a Cox model is assumed for the survival process, and
various association structures between both processes are provided.
4 Conclusions
The analysis of time until an event of interest is present in several applied fields. So, this paper has emphasised on the
specificity of the most popular survival modelling. In addition, it has focused on the Bayesian perspective to make the
inferential procedure, where for each survival modelling has been provided codes in BUGS syntax with the support of JAGS
and the rjags package for the R language.
We have discussed all the implementation details of the following Bayesian survival models: accelerated failure time,
proportional hazards, mixture cure, competing risks, frailty, and joint models of longitudinal and survival data. Moreover, we
hope that researchers who use survival models make their analyses based on the Bayesian paradigm from the simple codes we
have provided and easily adapt them to novel settings. The paper also briefly presents other Bayesian R-packages that handle
time-to-event data.
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